[1]华占楼,孙继妹,谢金春,等.早期小剂量地塞米松对急性胰腺炎治疗效果的影响[J].内科,2014,(05):531-533.
 HUA Zhan lou,SUN Ji mei,XIE Jin chun.Treatment effect of small dosage of dexamethsone in patients with acute pancreatitis in the early time[J].Internal Medicine of China,2014,(05):531-533.
点击复制

早期小剂量地塞米松对急性胰腺炎治疗效果的影响()
分享到:

《内科》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2014年05期
页码:
531-533
栏目:
论著
出版日期:
2014-10-31

文章信息/Info

Title:
Treatment effect of small dosage of dexamethsone in patients with acute pancreatitis in the early time
文章编号:
1673-7768(2014)05-0531-03
作者:
华占楼;孙继妹;谢金春;
江苏仪征市人民医院消化科,仪征市211400
Author(s):
HUA Zhanlou SUN Ji mei XIE Jinchun
Department of Gastroenterology, the People′s Hospital of yizheng city, Yizheng 211400, china
关键词:
急性胰腺炎地塞米松治疗
Keywords:
Acute pancreatitis Dexamethsone Treatment
分类号:
R576
文献标志码:
B
摘要:
目的探讨早期应用地塞米松对急性胰腺炎治疗效果的影响。方法将150例急性胰腺炎患者随机分为治疗一组、治疗二组、对照组,每组50例,对照组患者给予常规方法治疗;治疗一组在对照组治疗的基础上,从初入院开始立即给予小剂量地塞米松静脉注射;治疗二组在对照组治疗的基础上,当病情加重时给予小剂量地塞米松静脉注射。观察比较三组患者治疗后腹痛缓解时间、血清(尿)淀粉酶恢复时间、胰周渗出吸收好转及平均住院天数等。结果与对照组相比,治疗一组及二组腹痛缓解时间、血清(尿)淀粉酶恢复时间、胰周渗出吸收好转及平均住院天数均明显缩短(P<0.05);除血清淀粉酶恢复时间外,其他指标治疗一组比二组均缩短(P<0.05)。临床疗效比较,治疗一组优于对照组,但治疗二组与对照组比,差异无统计学意义。结论早期应用小剂量地塞米松可以明显降低血中炎症因子水平而降低胰腺炎程度,提高疗效。
Abstract:
ObjectiveTo study the treatment effect of small dosage of dexamethsone in patients with acute pancreatitis (AP) in the early time. Methods150 cases with AP were randomly allocated into three groups: treatment group one, treatment group two and control group, with 50 cases in each. Three groups were treated with conventional therapy, and the treatment group one was also received small dosage of dexamethsone as soon as be hospitalized, while treatment group two given small dosage of dexamethsone when the illness was worse. The time of abdominal pain relief, absorption of peripancreatic effusion and recovery time of serum amylase(urine), and the average hospitalization days were compared between the 3 groups. ResultsThe time of abdominal pain relief, absorption of peripancreatic effusion and recovery time of serum amylase (urine), and the average hospitalization days of treatment groups were significantly shorter than those of control group (P<0.05); in addition to the recovery time of serum amylase, the time of other indexes in the treatment group one was shorter than that of treatment group two (P<0.05). The clinical curative effect in the treatment group one was significantly better than that in the treatment group two, but there was no statistical difference between treatment group two and control group. ConclusionsSmall dosage of DXM in early time may reduce the severity of acute pancreatitis by restraining expression of acutephase tissue inflammatory factor.

参考文献/References:

[1]中华医学会外科学会胰腺学组.急性胰腺炎的临床诊断及分级标准(1996年第二次方案) [J].中华外科杂志,1997,35(12):773-775.
[2]Kingsnorth A.Role of cytokines and their inhibitors in acute pacreatitis[J].Gut,1997,40(1):1-4.
[3]Rau B,Baumgart K,Kruger CM,et al.CCchemokine activation in acute pancreatitis:enhanced release of monocyte chemoattractant protein1 in patients with local and systemic complications[J].Intensive Care Med,2003,29(5):622-629.
[4]华占楼.急性胰腺炎患者血清白介素2受体、白介素6和肿瘤坏死因子α的测定及其临床应用价值[J].医师进修杂志,2005,28(9A):27-28.
[5]马茂,耿志琴,和新颖,等.地塞米松抑制炎症介质改善重症急性胰腺炎的预后[J].第四军医大学学报,2002,23(10):932-934.
[6]张喜平,张玲,王英,等.地塞米松对重症急性胰腺炎大鼠多脏器损伤的保护作用[J].医学研究杂志,2006,35(11):19-23.
[7]董瑞,王自法,吕毅,等.早期大剂量地塞米松治疗重症急性胰腺炎的实验研究[J].肝胆外科杂志,2005,13(1):58-60.
[8]吕金利,李永研,李占京,等.地塞米松治疗急性胰腺炎的实验研究[J].实用医学杂志,2005,22(10):906-907.
[9]陈仲悦,李毅,李媚珍,等.大剂量地塞米松联合血液滤过在重症急性胰腺炎中的应用[J].中国基层医药,2005,12(8):1070-1071.
[10]涂巧丽,张世龙,石斌,等.地塞米松区域动脉灌注治疗重症急性胰腺炎的实验研究[J].中国普外基础与临床杂志,2011,18(12):1278-1282.

相似文献/References:

[1]覃奉道.35例急性胰腺炎的治疗体会[J].内科,2012,(02):148.
 [J].Internal Medicine of China,2012,(05):148.
[2]劳可娟.20例急性胰腺炎患者的护理[J].内科,2012,(03):324.
 [J].Internal Medicine of China,2012,(05):324.
[3]黄家财,卢文生.急性胰腺炎患者血浆降钙素原的变化及其意义[J].内科,2012,(05):463.
 HUANG Jia-cai,LU Wen-sheng.Predictive value of serum level of procalcitonin on the prognosis of patients with acute pancreatitis[J].Internal Medicine of China,2012,(05):463.
[4]罗江琳,张治红.重症急性胰腺炎护理进展[J].内科,2011,(05):499.
 [J].Internal Medicine of China,2011,(05):499.
[5]陈世奇.106例急性胰腺炎心肌酶谱变化分析[J].内科,2011,(06):566.
 [J].Internal Medicine of China,2011,(05):566.
[6]覃美兰.急性胰腺炎的护理体会[J].内科,2010,(04):440.
 [J].Internal Medicine of China,2010,(05):440.
[7]李桂桂.IKAP模式健康教育对急性胰腺炎患者自我效能感及生活质量的影响[J].内科,2016,(03):489.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.03.55]
 [J].Internal Medicine of China,2016,(05):489.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2016.03.55]
[8]陈鹏程,赵得良,李娜.美沙拉嗪联合磷酸铝凝胶治疗溃疡性结肠炎患者临床效果评价[J].内科,2017,12(02):235.[doi:10.16121/j.cnki.cn45-1347/r.2017.02.29]
[9]林薇,邓丽贞,司艳辉.BD方案联合环磷酰胺、吡柔比星治疗难治性多发性骨髓瘤患者临床观察[J].内科,2018,13(04):584.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.14]
 LIN Wei,DENG Lizhen,SI Yanhui.Clinical investigation of BD regimen combined with cyclophosphamide and pirarubicin in treatment of patients with refractory multiple myeloma[J].Internal Medicine of China,2018,13(05):584.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.14]
[10]陈惠霞,张英,赵春芳,等.多索茶碱联合地塞米松治疗煤工尘肺合并肺部感染临床疗效观察[J].内科,2018,13(05):724.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.05.14]
 CHEN Huixia,ZHANG Ying,ZHAO Chunfang,et al.The efficacy of doxofylline combined with dexamethasone in the treatment of coal-workers with pneumoconiosis complicated with pulmonary infection[J].Internal Medicine of China,2018,13(05):724.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.05.14]

更新日期/Last Update: 1900-01-01